Immunochemotherapy as First-line Treatment for Locally Advanced or Metastatic Squamous Non–Small Cell Lung Cancers

To the Editor We read with great interest the article by Wang et al.1 The results from the RATIONALE 307 phase 3 randomized clinical trial strengthened the evidence for immunochemotherapy as first-line treatment for locally advanced or metastatic squamous non–small cell lung cancers.